Genpact Limited
Income Statement
| Line Item | FY2017 | FY2016 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.74B | $2.57B | $2.28B | $2.13B | $1.90B | $1.60B | $1.26B | $1.12B |
| Cost of Revenue | $1.68B | $1.55B | $1.38B | $1.32B | $1.16B | $1.00B | $788.5M | $672.6M |
| Gross Profit | $1.06B | $1.02B | $901.4M | $812.4M | $744.2M | $595.5M | $470.4M | $447.4M |
| Gross Margin | 38.6% | 39.5% | 39.5% | 38.1% | 39.1% | 37.2% | 37.4% | 39.9% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $689.5M | $653.0M | $585.6M | $484.8M | $456.6M | $358.0M | $282.1M | $265.4M |
| Operating Income | $331.3M | $341.2M | $294.0M | $309.5M | $264.3M | $216.2M | $177.9M | $162.2M |
| Operating Margin | 12.1% | 13.3% | 12.9% | 14.5% | 13.9% | 13.5% | 14.1% | 14.5% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $320.6M | $329.6M | $249.6M | $306.2M | $263.0M | $262.1M | $184.2M | $161.1M |
| Income Tax Expense | $59.7M | $62.1M | $57.4M | $71.1M | $78.4M | $70.7M | $34.2M | $25.5M |
| Net Income | $263.1M | $269.7M | $192.0M | $229.7M | $178.2M | $184.3M | $142.2M | $127.3M |
| Net Margin | 9.6% | 10.5% | 8.4% | 10.8% | 9.4% | 11.5% | 11.3% | 11.4% |
| EPS (Basic) | $1.36 | $1.30 | $0.87 | $1.00 | $0.80 | $0.83 | $0.65 | $0.59 |
| EPS (Diluted) | $1.34 | $1.28 | $0.85 | $0.97 | $0.78 | $0.81 | $0.63 | $0.58 |
| Shares Outstanding (Basic) | 193.9M | 206.9M | 220.8M | 229.3M | 223.7M | 221.6M | 219.3M | 215.5M |
| Shares Outstanding (Diluted) | 197.0M | 210.1M | 225.2M | 235.8M | 229.5M | 226.4M | 224.8M | 220.1M |
| Dividends Per Share | $0.24 | $0.00 | — | — | $2.24 | — | — | — |